Profile
Martin Tolar is the founder of Alzheon, Inc., founded in 2013, serving as President, Chief Executive Officer & Director.
Former jobs include President & CEO at NormOxys, Inc. from 2009 to 2011; President, Chief Executive Officer & Director at Tafkak, Inc. in 2012; Director at BELLUS Health, Inc. in 2010; Independent Non-Executive Director at Suven Life Sciences Ltd. from 2011 to 2013; Principal at Pfizer Inc.; Chief Scientific Officer at CoMentis, Inc.; and Assistant Professor at Yale School of Medicine.
Education includes doctorates from the University of Cincinnati (Ohio) and the University of Charles.
Martin Tolar active positions
| Companies | Position | Start |
|---|---|---|
| ALZHEON, INC. | Founder | 2013-05-31 |
Former positions of Martin Tolar
| Companies | Position | End |
|---|---|---|
| BELLUS HEALTH | Director/Board Member | 2017-09-26 |
| SUVEN LIFE SCIENCES LIMITED | Director/Board Member | 2013-01-15 |
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome sequencing and analysis solutions | Chief Executive Officer | 2012-09-30 |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule therapeutics for the treatment of cancer | Chief Executive Officer | - |
Training of Martin Tolar
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
BELLUS Health, Inc.
BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease | Health Technology |
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule therapeutics for the treatment of cancer | Health Technology |
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome sequencing and analysis solutions | Commercial Services |
Alzheon, Inc.
Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
Suven Life Sciences Ltd.
Suven Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drug intermediates and chemicals | Health Technology |
University of Cincinnati (Ohio)
University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Charles
University of Charles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CoMentis, Inc.
CoMentis, Inc. Pharmaceuticals: MajorHealth Technology Focuses on developing drugs to treat various central nervous system disorders | Health Technology |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Martin Tolar
















